We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Self-Collection of Specimens for HPV Testing Is Feasible

By Biotechdaily staff writers
Posted on 11 Sep 2007
Although cytology-screening programs for human papillomavirus (HPV) are available in developed countries, not all women make full use of them. The feasibility of using self-collected specimens for testing human papillomavirus (HPV) status among hard-to-reach women was studied in British Columbia.

Outreach nurses, recruited women in women's centers, shelters, and alleys in Vancouver's (Canada) downtown Eastside section. Participants were given a diagram that illustrated how to obtain a cervicovaginal specimen. They then placed the specimen in a tube containing Digene (Gaithersburg, MD, USA) specimen transport medium. Women were asked to collect the specimen immediately at the closest washroom or private location and to return it to the nurse.

Samples were transported to the British Columbia Center for Disease Control (Vancouver, British Columbia, Canada) within 24 hours of collection. They were analyzed for the presence of high-risk HPV DNA using the Digene HPV test, according to the manufacturer's instructions. Of the 151 participants whose specimens that were analyzed, 43 were positive for high-risk HPV. The women who tested positive were significantly younger; less educated, and reported having had more sex-trade partners than women who tested negative.

About 14% (21/151) of participants had never received a Papanicolaou smear in British Columbia (BC, Canada), as compared with 8.3% (608/7336) of women in the BC general population. This difference suggests that self-collection of specimens for HPV testing is a practical method to reach women who have not previously participated in cervical cancer screening programs.

The study was initiated by Dr. Gina Ogilvie, assistant professor, University of British Columbia (Vancouver, Canada) and was published in the August 2007 issue of the Canadian Medical Association Journal (CMAJ).


Related Links:
British Columbia Center for Disease Control
Digene
University of British Columbia

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
All-in-One Molecular System
AIO M160
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA

Latest BioResearch News

Single-Cell Method Measures RNA and Proteins to Reveal Immune Responses
11 Sep 2007  |   BioResearch

Study Links Midlife Vitamin D to Lower Tau in Alzheimer's
11 Sep 2007  |   BioResearch

International Consensus Standardizes Tumor Microbiota Detection and Reporting
11 Sep 2007  |   BioResearch